This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
IDE Monoclonal Antibody (334501)
catalog :
MA5-24064
quantity :
100 ug
price :
US 414.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human
application :
western blot, flow cytometry
product information
Product Type :
Antibody
Product Name :
IDE Monoclonal Antibody (334501)
Catalog # :
MA5-24064
Quantity :
100 ug
Price :
US 414.00
Clonality :
Monoclonal
Purity :
Protein A/G
Host :
Mouse
Reactivity :
Human
Applications :
Flow Cytometry: 2.5 ug per million cells, Western Blot: 1 ug/mL
Species :
Human
Clone :
334501
Isotype :
IgG1
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
This gene may belong to a protease family responsible for intercellular peptide signalling. Though its role in the cellular processing of insulin has not yet been defined, insulin-degrading enzyme is thought to be involved in the termination of the insulin response.
Immunogen :
Sf 21-derived recombinant human Insulysin/IDE Met42-Leu1019
Format :
Lyophilized
Applications w/Dilutions :
Flow Cytometry: 2.5 ug per million cells, Western Blot: 1 ug/mL
Aliases :
1300012G03Rik; 4833415K22Rik; AA675336; Abeta-degrading protease; AI507533; FLJ35968; Ide; INSDEGM; Insulin degrading enzyme; insulin protease; insulinase; Insulin-degrading enzyme; Insulysin; zgc:162603
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments